The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with prostatectomy.
Jay T. Bishoff
Research Funding - Myriad Genetics
Stephen J. Freedland
Consultant or Advisory Role - Bayer
Honoraria - AstraZeneca
Research Funding - Abbott Laboratories
Leah Gerber
No relevant relationships to disclose
Pierre Tennstedt
No relevant relationships to disclose
William Welbourn
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Julia E. Reid
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Markus Graefen
No relevant relationships to disclose
Zaina Sangale
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Eliso Tikishvili
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Jimmy Park
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Adib Younus
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Alexander Gutin
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Jerry S. Lanchbury
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Guido Sauter
No relevant relationships to disclose
Michael K. Brawer
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Steven Stone
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Thorsten Schlomm
No relevant relationships to disclose